Search

CHEK2 P/LP variants are inherited in an autosomal dominant fashion. People with CHEK2 have an increased risk of developing breast and prostate cancer.

Familial Adenomatous Polyposis (FAP) is a very rare condition that accounts for about 1% of new cases of colorectal cancer. People with FAP typically develop hundreds to thousands of polyps (adenomas) in their colon and rectum by age 30-40. FAP is caused by mutations in the adenomatous polyposis coli (APC) gene.

UT Southwestern is experienced in providing care for people with hereditary paraganglioma-pheochromocytoma syndrome.

UT Southwestern is home to one of the largest hereditary cancer programs in the country, providing expert care for individuals with Li-Fraumeni syndrome.

Lynch syndrome is an inherited cancer risk condition that increases a person’s chances of developing multiple types of cancer. It is caused by mutations, or breaks, of the MLH1, MSH2, MSH6, PMS2, or EPCAM genes.

UT Southwestern is home to one of the largest hereditary cancer programs in the country, providing expert care for individuals with PALB2 P/LP variants.

UT Southwestern cancer doctors offer the latest myeloma diagnosis and staging methods, such as advanced imaging and genetic testing.

UT Southwestern’s approach to treating myeloma, a bone marrow cancer, can include medications or bone marrow transplant, depending on the personalized plan of care.

UT Southwestern offers clinical trials for myeloma, cancer of the plasma cells in bone marrow. Such trials often are not available anywhere else in the region.

UT Southwestern provides support services for patients with myeloma and their families to guide them through treatment and answer any questions.